245 related articles for article (PubMed ID: 23053181)
21. Inverse correlation between VEGF and soluble VEGF receptor 2 in POEMS with AIDP responsive to intravenous immunoglobulin.
Terracciano C; Fiore S; Doldo E; Manzari V; Marfia GA; Bernardi G; Massa R; Albonici L
Muscle Nerve; 2010 Sep; 42(3):445-8. PubMed ID: 20589895
[TBL] [Abstract][Full Text] [Related]
22. Remarkable expression of vascular endothelial growth factor in bone marrow plasma cells of patients with POEMS syndrome.
Wang C; Huang XF; Cai QQ; Cao XX; Cai H; Zhou D; Li J
Leuk Res; 2016 Nov; 50():78-84. PubMed ID: 27697660
[TBL] [Abstract][Full Text] [Related]
23. Relapse of polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome without increased level of vascular endothelial growth factor following successful autologous peripheral blood stem cell transplantation.
Imai N; Taguchi J; Yagi N; Konishi T; Serizawa M; Kobari M
Neuromuscul Disord; 2009 May; 19(5):363-5. PubMed ID: 19269178
[TBL] [Abstract][Full Text] [Related]
24. [Electrophysiologic aspects of Crow-Fukase (POEMS) syndrome--significance in early diagnosis and insights into the pathophysiology].
Misawa S
Brain Nerve; 2008 Jun; 60(6):595-601. PubMed ID: 18567354
[TBL] [Abstract][Full Text] [Related]
25. [New treatment strategy for Crow-Fukase (POEMS) syndrome].
Kuwabara S
Rinsho Shinkeigaku; 2010 Nov; 50(11):794-6. PubMed ID: 21921444
[TBL] [Abstract][Full Text] [Related]
26. Japanese POEMS syndrome with Thalidomide (J-POST) Trial: study protocol for a phase II/III multicentre, randomised, double-blind, placebo-controlled trial.
Katayama K; Misawa S; Sato Y; Sobue G; Yabe I; Watanabe O; Nishizawa M; Kusunoki S; Kikuchi S; Nakashima I; Ikeda S; Kohara N; Kanda T; Kira J; Hanaoka H; Kuwabara S;
BMJ Open; 2015 Jan; 5(1):e007330. PubMed ID: 25573527
[TBL] [Abstract][Full Text] [Related]
27. [Two cases of POEMS syndrome with increased vascular endothelial growth factor (VEGF)].
Arimura H; Watanabe O; Arimura K; Maruyama I; Hokezu Y
Rinsho Shinkeigaku; 1997 Sep; 37(9):817-23. PubMed ID: 9430997
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation.
Vannata B; Laurenti L; Chiusolo P; Sorà F; Balducci M; Sabatelli M; Luigetti M; Giannotta C; De Stefano V; Leone G; Sica S
Am J Hematol; 2012 Jun; 87(6):641-2. PubMed ID: 22488443
[TBL] [Abstract][Full Text] [Related]
29. POEMS syndrome treated with melphalan high-dose therapy and autologous blood stem cell transplantation: a single-institution experience.
Thoennissen GB; Thoennissen NH; Fritz F; Hilbig A; Kerkhoff A; Liersch R; Krug U; Koschmieder S; Müller-Tidow C; Mesters R; Kropff M; Berdel WE
Ann Hematol; 2012 Sep; 91(9):1419-25. PubMed ID: 22543828
[TBL] [Abstract][Full Text] [Related]
30. POEMS in childhood.
Marina S; Broshtilova V
Pediatr Dermatol; 2006; 23(2):145-8. PubMed ID: 16650224
[TBL] [Abstract][Full Text] [Related]
31. Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.
Miralles GD; O'Fallon JR; Talley NJ
N Engl J Med; 1992 Dec; 327(27):1919-23. PubMed ID: 1333569
[TBL] [Abstract][Full Text] [Related]
32. Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.
He T; Zhao A; Zhao H; Cai H; Feng J; Zhang L; Cao X; Zhou D; Li J
Ann Hematol; 2019 Mar; 98(3):735-743. PubMed ID: 30612232
[TBL] [Abstract][Full Text] [Related]
33. [POEMS syndrome: a review of the literature].
Méndez-Herrera CR; Cordoví-Rodríguez D
Rev Neurol; 2011 Jul; 53(1):44-50. PubMed ID: 21678324
[TBL] [Abstract][Full Text] [Related]
34. A case of POEMS syndrome with cystoid macular edema.
Imai H; Kusuhara S; Nakanishi Y; Teraoka Escaño MF; Yamamoto H; Tsukahara Y; Negi A
Am J Ophthalmol; 2005 Mar; 139(3):563-6. PubMed ID: 15767082
[TBL] [Abstract][Full Text] [Related]
35. Successful treatment with rituximab and thalidomide of POEMS syndrome associated with Waldenstrom macroglobulinemia.
Kawano Y; Nakama T; Hata H; Kimura E; Maruyoshi N; Uchino M; Mitsuya H
J Neurol Sci; 2010 Oct; 297(1-2):101-4. PubMed ID: 20673674
[TBL] [Abstract][Full Text] [Related]
36. Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma.
Vacca A; Scavelli C; Montefusco V; Di Pietro G; Neri A; Mattioli M; Bicciato S; Nico B; Ribatti D; Dammacco F; Corradini P
J Clin Oncol; 2005 Aug; 23(23):5334-46. PubMed ID: 15939924
[TBL] [Abstract][Full Text] [Related]
37. Intractable ascites, changes in serum vascular endothelial growth factor levels and thalidomide treatment in POEMS syndrome.
Wu KL; Chen HW; Lin SH; Chen JS
Am J Med Sci; 2014 Jun; 347(6):510-2. PubMed ID: 24781436
[No Abstract] [Full Text] [Related]
38. [POEMS syndrome diagnosed by detection of M-protein on immunofixation and increased level of vascular endothelial growth factor].
Hattori Y; Taguchi J; Imai N; Wasano K; Matsuura S; Koharazawa H; Ishigatsubo Y; Fujisawa S
Rinsho Ketsueki; 2011 Apr; 52(4):219-22. PubMed ID: 21566409
[TBL] [Abstract][Full Text] [Related]
39. Pentraxin-3 and VEGF in POEMS syndrome: a 2-year longitudinal study.
Briani C; Dalla Torre C; Lessi F; Cavallaro T; Scarlato M; Ferrari S; Campagnolo M; Lucchetta M; Cabrini I; Morbin M; Lauria G; Adami F; Manfredi AA
J Neuroimmunol; 2014 Dec; 277(1-2):189-92. PubMed ID: 25447599
[TBL] [Abstract][Full Text] [Related]
40. [Crow-Fukase (POEMS) syndrome].
Kuwabara S
Brain Nerve; 2010 Apr; 62(4):395-400. PubMed ID: 20420180
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]